YVONNE CHESNA: Open Payments
NPI 1346338506 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 97 payments from 18 companies in 2025. Trend: 2023 $1,348 · 2024 $1,820 · 2025 $1,559
Food & beverage: $1,550Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $358 |
| Janssen Biotech, Inc. | 16 | $194 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $160 |
| GENZYME CORPORATION | 9 | $147 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| UCB, Inc. | 3 | $89 |
| LEO Pharma Inc. | 4 | $83 |
| Incyte Corporation | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Lilly USA, LLC | 2 | $47 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, ILUMYA, RINVOQ, Bimzelx, ADBRY, COSENTYX.
Industry payments across NY — which companies pay providers there.
